Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


15th Annual Drug Discovery Leaders Summit

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland



Bookmark and Share


Attend Europe’s leading networking and discussion platform for drug discovery professionals.  

Meet 250 senior-level delegates from global pharmaceutical organisations, leading biotechs and esteemed academic institutions.

Hear 60 expert speakers discuss the pressing challenges in medicinal chemistry, compound screening, target-based discovery and innovation access.

Discuss the viability of the latest discovery trends, including phenotypic screening, epigenetic drug discovery, stem cell technology and nanoengineering.

Tailor your congress experience – attend any sessions from the following six streams:

- R&D Models For The Future

- Screening & Assays: Enabling Technologies

- Target Based Discovery

- Supporting Innovation: Data & Information Management

- Discovery Chemistry: Latest Case Studies

- Drug Design: Novel Approaches

The Summit is co-located with the 6th Annual Drug Development Congress - an executive level event focusing on predictive science and translational medicine.

The Drug Discovery Summit is Europe’s leading networking and discussion platform for pharmaceutical professionals. Attending this long-established event gives delegates the opportunity to:

Hear from and meet with the people shaping the pharmaceutical landscape. Previous attendees include: Vice President New Frontier Science Europe, Takeda; Vice President and Venture Leader, Janssen R&D; Vice President & Global Head, Reagents & Assay Development, AstraZeneca.

Discuss the latest discovery innovations, including 3D cell based assays, advances in nanoengineering and iPSCs for compound screening.

Discover collaborative solutions to discovery challenges. This summit brings together a host of experts to compare methods for utilising new screening technology, validating novel drug targets, improving lead optimisation and making better use of discovery data.

Enjoy unparalleled networking opportunities. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion.

Tailor the congress experience.  The six stream agenda offers industry updates for those working in discovery technology, target-based discovery, discovery information, discovery chemistry, drug design, research strategy and open innovation.

Contact Danielle Dalby to download the agenda and for attendance information on d.dalby@oxfordgloabl.co.uk or call +44 (0)1865 248455



Further information
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!